Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (Loss) Income	$ (29,655)	$ (74,286)	$ 103,135
Depreciation and amortization	228,774	235,151	89,698
Amortization of Inventory Step-up	0	26,519	0
Operating Lease, Right-of-Use Asset, Amortization Expense	21,910	23,651	9,594
Provision for doubtful accounts	838	1,036	345
Provision for warranty and returns	21,582	4,902	831
Stock compensation	40,563	36,025	27,341
Loss on Disposition of Property Plant Equipment, net	2,109	2,010	1,652
Bond premium amortization	17	264	655
Debt issuance cost amortization	6,814	6,972	240
Change in fair value of contingent earn-out	(16,247)	(32,091)	0
Production Related Impairments or Charges	0	0	3,380
Sparepartsusage	17,050	11,924	13,046
Other	8,049	(477)	2,582
Increase (Decrease) in Accounts Receivable	48,635	(19,151)	13,755
Increase (Decrease) in Inventories	(6,079)	(201,095)	20,815
Increase (Decrease) in Prepaid Expense and Other Assets	11,672	22,903	(7,973)
Increase (Decrease) in Other Operating Assets	(24,695)	(21,290)	(21,038)
Accounts payable	(68,301)	37,472	2,347
Accrued liabilities	(14,479)	(55,834)	6,259
Income taxes, including excess tax benefits and deferred income taxes	(82,356)	(66,734)	874
Net cash provided by (used in)operating activities	166,201	(62,129)	267,538
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(83,893)	(90,311)	(68,542)
Proceeds from sale of assets	1,501	989	218
Intangible asset additions	(9,777)	(9,018)	(12,627)
Business acquisitions, net of cash acquired	0	(1,844,164)	(14,452)
Payments to Acquire Equity Method Investments	0	0	(3,250)
Purchases of investment securities	0	(3,397)	(10,034)
Proceeds from sale of investment securities	4,222	36,433	18,000
Net cash used in by investing activities	(87,947)	(1,909,468)	(90,687)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of long-term debt, net of lender debt issuance costs	0	1,664,362	0
Repayments of Long-term obligations	(29,688)	(22,375)	0
Payments of Debt Issuance Costs	0	(2,177)	0
Proceeds from exercise of stock options	4,022	8,785	9,372
Payments on finance leases	(963)	(680)	(607)
Payment for Contingent Consideration Liability, Financing Activities	0	0	(17,300)
Purchase of treasury stock	(9,350)	(10,883)	(8,335)
Net cash (used in) provided by financing activities	(35,979)	1,637,032	(16,870)
Effect of Exchange Rate on Cash [Abstract]
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations	3,163	(9,478)	(3,251)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Total	45,438	(344,043)	156,730
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	254,222	208,784	552,827
SUPPLEMENTAL DISCLSOURE OF CASH FLOW INFORMATION
Cash paid during the year for income taxes	35,809	27,504	19,562
Interest Paid, Excluding Capitalized Interest, Operating Activities	95,913	63,713	858
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Accounts payable for property, plant and equipment	6,570	4,854	9,338
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable			0
Smiths Medical
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Fair value of assets acquired		1,606,300
Cash paid for acquisitions, net of cash acquired		(1,844,164)
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		(575,975)
Contingent consideration		(55,158)
Goodwill, Period Increase (Decrease)		1,462,752
Liabilities Assumed		593,755
International Distributor
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Noncash Non-compete agreement with associated contingent earn-out liability	$ 0	$ 0	2,589
Foreign Infusion System Supplier
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING ACTIVITIES
Fair value of assets acquired			4,592
Cash paid for acquisitions, net of cash acquired			(14,452)
Contingent consideration			0
Goodwill, Period Increase (Decrease)			10,626
Liabilities Assumed			$ 766